InvestorsObserver is giving Idera Pharmaceuticals Inc (IDRA) an Analyst Rating Rank of 4, meaning IDRA is ranked higher by analysts than 4% of stocks. The average price target for IDRA is $2 and analyst’s rate the stock as a Hold.
Wall Street analysts are rating IDRA a Hold today. Find out what this means to you and get the rest of the rankings on IDRA!